Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Let's dive into a talk with Ayla Ellison, Strong Biotech Managing Editor as well as Michelle Benz a...

New data demonstrate how Bayer's asundexian failed to avoid strokes

.Bayer suspended the stage 3 trial for its aspect XIa inhibitor asundexian behind time last year aft...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its a number of sclerosis (MS) med tolebrutinib to the FD...

Galapagos' stock up as fund shows intent to mold its evolution

.Galapagos is actually happening under additional tension coming from financiers. Having developed a...

Cell- focused Sana scoops first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings as...

Allist settles Jacobio $21M, landing function in Mandarin KRAS nationality

.Shanghai Allist Pharmaceuticals has bought itself a starring role in China's KRAS market, paying Ja...

ReNeuron leaving AIM swap after missing out on fundraising goal

.ReNeuron has signed up with the long list of biotechs to leave behind London's intention securities...

MBX declare IPO to take opposition to Ascendis into stage 3

.MBX Biosciences has contributed to the recent flurry of IPO filings. The biotech, which filed its p...

FDA broadens probe in to Lykos' MDMA trials: WSJ

.For Lykos Therapeutics and also the firm's potential MDMA-assisted treatment for trauma (PTSD), the...

Gene editor Tome laying off 131 workers

.Just days after genetics publisher Tome Biosciences revealed concealed operational cuts, a more cle...